Xu L - Search Results

1

The role of osteopontin in the induction of the CD40 ligand in Graves' disease.

Qi Y, Li X, Ma X, Xu L, Zhang X, Jiang X, Hong J, Cui B, Ning G, Wang S. Qi Y, et al. Among authors: xu l. Clin Endocrinol (Oxf). 2014 Jan;80(1):128-34. doi: 10.1111/cen.12229. Epub 2013 Jun 3. Clin Endocrinol (Oxf). 2014. PMID: 23617736

2

Loss of steroid receptor co-activator-3 attenuates carbon tetrachloride-induced murine hepatic injury and fibrosis.

Ma X, Xu L, Wang S, Chen H, Xu J, Li X, Ning G. Ma X, et al. Among authors: xu l, xu j. Lab Invest. 2009 Aug;89(8):903-14. doi: 10.1038/labinvest.2009.51. Epub 2009 Jun 1. Lab Invest. 2009. PMID: 19488034 Free PMC article.

3

SRC-3 deficient mice developed fat redistribution under high-fat diet.

Xu L, Ma X, Li J, Li X, Xu J, Wang S, Ning G. Xu L, et al. Among authors: xu j. Endocrine. 2010 Aug;38(1):60-6. doi: 10.1007/s12020-010-9344-2. Epub 2010 May 7. Endocrine. 2010. PMID: 20960103

4

Selection of reference genes for qRT-PCR in high fat diet-induced hepatic steatosis mice model.

Xu L, Ma X, Cui B, Li X, Ning G, Wang S. Xu L, et al. Mol Biotechnol. 2011 Jul;48(3):255-62. doi: 10.1007/s12033-010-9366-2. Mol Biotechnol. 2011. PMID: 21184202

5

Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis.

Ma X, Xu L, Wang S, Cui B, Li X, Xu J, Ning G. Ma X, et al. Among authors: xu l, xu j. J Hepatol. 2011 Aug;55(2):445-52. doi: 10.1016/j.jhep.2010.11.022. Epub 2010 Dec 22. J Hepatol. 2011. PMID: 21184786

6

A genome-wide association study confirms previously reported loci for type 2 diabetes in Han Chinese.

Cui B, Zhu X, Xu M, Guo T, Zhu D, Chen G, Li X, Xu L, Bi Y, Chen Y, Xu Y, Li X, Wang W, Wang H, Huang W, Ning G. Cui B, et al. Among authors: xu l, xu m, xu y. PLoS One. 2011;6(7):e22353. doi: 10.1371/journal.pone.0022353. Epub 2011 Jul 22. PLoS One. 2011. PMID: 21799836 Free PMC article.

7

The expression and pathophysiological role of osteopontin in Graves' disease.

Xu L, Ma X, Wang Y, Li X, Qi Y, Cui B, Li X, Ning G, Wang S. Xu L, et al. J Clin Endocrinol Metab. 2011 Nov;96(11):E1866-70. doi: 10.1210/jc.2011-1339. Epub 2011 Sep 7. J Clin Endocrinol Metab. 2011. PMID: 21900386

8

Differential microRNA expression in peripheral blood mononuclear cells from Graves' disease patients.

Liu R, Ma X, Xu L, Wang D, Jiang X, Zhu W, Cui B, Ning G, Lin D, Wang S. Liu R, et al. Among authors: xu l. J Clin Endocrinol Metab. 2012 Jun;97(6):E968-72. doi: 10.1210/jc.2011-2982. Epub 2012 Mar 28. J Clin Endocrinol Metab. 2012. PMID: 22456620

9

Chemokine (C-C motif) ligand 20, a potential biomarker for Graves' disease, is regulated by osteopontin.

Li X, Qi Y, Ma X, Huang F, Guo H, Jiang X, Hong J, Lin D, Cui B, Ning G, Xu L, Wang S. Li X, et al. Among authors: xu l. PLoS One. 2013 May 22;8(5):e64277. doi: 10.1371/journal.pone.0064277. Print 2013. PLoS One. 2013. PMID: 23717583 Free PMC article.

10

Role of forkhead box protein A3 in age-associated metabolic decline.

Ma X, Xu L, Gavrilova O, Mueller E. Ma X, et al. Among authors: xu l. Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14289-94. doi: 10.1073/pnas.1407640111. Epub 2014 Sep 15. Proc Natl Acad Sci U S A. 2014. PMID: 25225406 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,275 results

Search Page

Filters